Bajaj Healthcare Ltd Share Price & Stock Analysis

Bajaj Healthcare Ltd (BSE: 539872) is a Thane, Maharashtra-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹1,096 Cr, it ranks #1,529 by market cap among the 6,197 Indian listed companies on FinBizNet, and #45 of 86 in Medicinal Chemicals and Botanical Products. At ₹323.05 (as of 16 Nov 2026), the share price is 29.5% below its 52-week high of ₹458.00 and 18.6% above its 52-week low of ₹272.35. The share price is down 27.0% over one year and down 2.4% over three months.

Key Metrics

Current Price₹323.05
Market Cap₹1,096 Cr
BSE Code539872
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Medicinal Chemicals and Botanical Products
P/E Ratio48.5
Return on Equity4.27%
Return on Assets5.51%
52-Week Range₹272.35 – ₹458.00
1-Year Price Change-27.0%
3-Month Price Change-2.4%
Beta (1Y)0.38
Dividend Yield0.46%
HeadquartersThane, Maharashtra
Websitewww.bajajhealth.com

Latest Quarterly Results — Q2 FY27

Revenue₹176 Cr
Net Profit₹14 Cr
Net Margin8.0%
EPS (Basic)₹4.27
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Bajaj Healthcare Ltd Quarterly Revenue and Profit Trend

Bajaj Healthcare Ltd reported revenue of ₹176 Cr in Q2 FY27, up 18.9% from ₹148 Cr in Q2 FY26 and up 6.2% from ₹166 Cr in Q1 FY27. It posted a net profit of ₹14 Cr for the quarter, against a net profit of ₹11 Cr in Q2 FY26 (up 26.8%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹148 Cr (Q2 FY26) to ₹176 Cr (Q2 FY27). The company reported a net loss in 1 of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹176 Cr₹14 Cr8.0%
Q1 FY27₹166 Cr₹14 Cr8.3%
Q4 FY26₹153 Cr−₹23 Cr−14.9%
Q3 FY26₹161 Cr₹16 Cr9.7%
Q2 FY26₹148 Cr₹11 Cr7.5%
Q1 FY26₹149 Cr₹12 Cr7.9%
Q4 FY25₹154 Cr₹11 Cr7.2%

Standalone figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 58.59% of Bajaj Healthcare Ltd's shares as of Sept 2026, against 59.19% in Sept 2025 (−0.60 percentage points). Delivery averaged 48.1% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Bajaj Healthcare Ltd

Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, markets, and sells active pharmaceutical ingredient, intermediates, and finished dosage forms and nutraceuticals for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company offers active pharmaceutical ingredient in various therapeutic categories, including anti-diabetic, antibiotic, antiviral, antiplatelet, antifungal, antihelmintic, iron-chelating agent, anticonvulsant, growth stimulant, non-steroidal anti-inflammatory drugs, antihypertensive, anthelmintics, anti-asthmatic, antioxidant, urinary tract infection, anti-histamine, weight reducing, phlebotropic drug, antimalarial, vitamin c, disinfectant/ antiseptic, stimulant, lipotropic agents, nootropic, vasoprotective/antihemorrhagic, cardiovascular agents, food supplements, anti-anemic, amino acids, antiasthmatic / bronchodilator, nutritional supplement, and minerals. It provides intermediates, such as guanine, 3-methyl x

Products and Services

1. Pharma-This segment engages in the API and formulation business. 2. Bulk Drugs-This segment manufactures and sells bulk drugs. 3. Formulations-This segment manufactures and markets active pharmaceutical ingredients, intermediates, and finished dosage formulations with focus on vitamins, amino acids, anti-convulsants, and finished dosage forms catering various therapeutic applications. 4. Intersegment Revenue-0

Bajaj Healthcare Ltd vs Peers — Medicinal Chemicals and Botanical Products

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Sun Pharmaceutical Industries Limited₹4,56,425 Cr39.514.72%₹16,199 Cr+11.2%
Laurus Labs Ltd₹1,31,242 Cr145.617.74%₹2,206 Cr+146.8%
Zydus Lifesciences Ltd₹1,19,651 Cr24.118.32%₹7,910 Cr+26.0%
Dr.Reddys Lab₹1,15,464 Cr26.911.52%₹8,698 Cr+14.5%
Cipla Limited₹1,14,712 Cr29.311.74%₹7,404 Cr-7.6%
Mankind Pharma₹1,09,870 Cr5712.45%₹4,338 Cr+16.7%
Aurobindo Pharma Ltd.₹1,05,150 Cr309.93%₹10,263 Cr+59.8%
Lupin Ltd₹92,087 Cr17.326.91%₹7,827 Cr+0.4%
Bajaj Healthcare Ltd₹1,096 Cr48.54.27%₹176 Cr-27.0%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Bajaj Healthcare Ltd?

Bajaj Healthcare Ltd is trading at ₹323.05, with a market capitalisation of ₹1,096 Cr.

Which sector does Bajaj Healthcare Ltd belong to?

Bajaj Healthcare Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).

What are the key financial ratios of Bajaj Healthcare Ltd?

Bajaj Healthcare Ltd has a P/E of 48.5 and a return on equity of 4.27%.

What is the stock symbol of Bajaj Healthcare Ltd?

Bajaj Healthcare Ltd is listed on the BSE under the scrip code 539872.

How has Bajaj Healthcare Ltd's share price moved over the past year?

Bajaj Healthcare Ltd's share price is down 27.0% over one year and down 2.4% over three months. Its 52-week range is ₹272.35 to ₹458.00.

What were Bajaj Healthcare Ltd's latest quarterly results?

In Q2 FY27, Bajaj Healthcare Ltd reported revenue of ₹176 Cr and net profit of ₹14 Cr, with basic EPS of ₹4.27 (standalone, parsed from the company's exchange filing).

How have Bajaj Healthcare Ltd's revenue and profit changed over the past year?

Bajaj Healthcare Ltd reported revenue of ₹176 Cr in Q2 FY27, up 18.9% from ₹148 Cr in Q2 FY26 and up 6.2% from ₹166 Cr in Q1 FY27.

What is the promoter holding in Bajaj Healthcare Ltd?

Promoters held 58.59% of Bajaj Healthcare Ltd's shares as of Sept 2026, against 59.19% in Sept 2025 (−0.60 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.